Submitted by Catherine Atkins on Tue, 04/10/2022 - 16:51
Harvey and his team are working on the theory that we may be able to spot patterns in our DNA that could help identify the best cancer treatment type for each person as an individual. Some people respond better to treatments such as radiotherapy and chemotherapy - known as DNA damaging agents (DDAs) - than others. With an initial Prostate Cancer Research grant, the team have developed a new screening platform for prostate cancer, using the DNA taken from men during biopsies, to identify patterns in the DNA which might help distinguish those who will react well to the aggressive treatment from those who won't.
This additional funding from Prostate Cancer Research will allow the team to work towards a clinical application of ProCASP which will enable doctors to identify which therapy will work best for each patient, with the ultimate aim of saving more lives.